Distribution of seizures across the menstrual cycle in women with epilepsy

被引:40
作者
Herzog, Andrew G. [1 ]
Fowler, Kristen M. [1 ]
Sperling, Michael R. [2 ]
Massaro, Joseph M. [3 ]
机构
[1] Beth Israel Deaconess Med Ctr, Harvard Neuroendocrine Unit, Boston, MA 02215 USA
[2] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[3] Harvard Clin Res Inst, Boston, MA USA
关键词
Epilepsy; Seizures; Women; Catamenial; Clinical trials randomized controlled; CATAMENIAL EPILEPSY; PROGESTERONE;
D O I
10.1111/epi.12969
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The purpose of this study was to determine whether seizure frequency and cycle days with seizure occurrence vary across the menstrual cycle. The subjects were the first 100 women with intractable focal onset seizures, 13-45years old, who completed the baseline phase of the National Institutes of Health (NIH) Progesterone Trial. Each subject recorded seizures and menses during a 3-month baseline phase. Data consisted of (1) seizure numbers for each cycle day and (2) cycle days with seizure occurrence. Statistical comparisons of seizure frequency and days with seizures were performed using generalized estimating equation one-way analysis of variance (ANOVA) and logistic regression followed by pairwise multiple comparisons of days based on the least square means. Seizure numbers and cycle days with seizure occurrence varied across the menstrual cycle. There was an approximately twofold difference between the highest (day 1) and lowest (day -8) values for both seizure frequency and days with occurrence. The demonstration of variation in seizure frequency and cycle days with seizure occurrence across the menstrual cycle, as well as identification of specific days that have substantially higher or lower frequencies than other days, supports the existence of catamenial epilepsy.
引用
收藏
页码:E58 / E62
页数:5
相关论文
共 10 条
  • [1] BACKSTROM T, 1976, ACTA NEUROL SCAND, V54, P321
  • [2] Progesterone vs placebo therapy for women with epilepsy A randomized clinical trial
    Herzog, A. G.
    Fowler, K. M.
    Smithson, S. D.
    Kalayjian, L. A.
    Heck, C. N.
    Sperling, M. R.
    Liporace, J. D.
    Harden, C. L.
    Dworetzky, B. A.
    Pennell, P. B.
    Massaro, J. M.
    [J]. NEUROLOGY, 2012, 78 (24) : 1959 - 1966
  • [3] Three patterns of catamenial epilepsy
    Herzog, AG
    Klein, P
    Ransil, BJ
    [J]. EPILEPSIA, 1997, 38 (10) : 1082 - 1088
  • [4] Catamenial epilepsy: Definition, prevalence pathophysiology and treatment
    Herzog, Andrew G.
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2008, 17 (02): : 151 - 159
  • [5] Allopregnanolone levels and seizure frequency in progesterone-treated women with epilepsy
    Herzog, Andrew G.
    Frye, Cheryl A.
    [J]. NEUROLOGY, 2014, 83 (04) : 345 - 348
  • [6] GABAergic transmission in temporal lobe epilepsy: The role of neurosteroids
    Joshi, Suchitra
    Rajasekaran, Karthik
    Kapur, Jaideep
    [J]. EXPERIMENTAL NEUROLOGY, 2013, 244 : 36 - 42
  • [7] LAIDLAW J, 1956, LANCET, V271, P1235
  • [8] Ovarian cycle-linked changes in GABAA receptors mediating tonic inhibition alter seizure susceptibility and anxiety
    Maguire, JL
    Stell, BM
    Rafizadeh, M
    Mody, I
    [J]. NATURE NEUROSCIENCE, 2005, 8 (06) : 797 - 804
  • [9] Circalunar and ultralunar periodicities in women with partial seizures
    Quigg, Mark
    Fowler, Kristen M.
    Herzog, Andrew G.
    [J]. EPILEPSIA, 2008, 49 (06) : 1081 - 1085
  • [10] GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid
    Smith, SS
    Gong, QH
    Hsu, FC
    Markowitz, RS
    ffrench-Mullen, JMH
    Li, HS
    [J]. NATURE, 1998, 392 (6679) : 926 - 930